nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
ADAMTS10 inhibits aggressiveness via JAK/STAT/c-MYC pathway and reprograms macrophage to create an anti-malignant microenvironment in gastric cancer
|
Zhou, Junyi |
|
|
25 |
6 |
p. 1002-1016 |
artikel |
2 |
A retrospective 5-year survival analysis of surgically resected gastric cancer cases from the Japanese Gastric Cancer Association nationwide registry (2001–2013)
|
Kakeji, Yoshihiro |
|
|
25 |
6 |
p. 1082-1093 |
artikel |
3 |
Comment on: “Internal hernia after gastrectomy for gastric cancer in minimally invasive surgery era,” Gastric Cancer, 2019 Feb 13, by Kang et al
|
Shao, Xinxin |
|
|
25 |
6 |
p. 1125-1126 |
artikel |
4 |
Correction to: DNA methylation downregulated mir-10b acts as a tumor suppressor in gastric cancer
|
Li, Zheng |
|
|
25 |
6 |
p. 1136-1138 |
artikel |
5 |
Correction to: Propionibacterium acnes overabundance in gastric cancer promote M2 polarization of macrophages via a TLR4/PI3K/Akt signaling
|
Li, Qing |
|
|
25 |
6 |
p. 1139-1141 |
artikel |
6 |
Deep learning predicts resistance to neoadjuvant chemotherapy for locally advanced gastric cancer: a multicenter study
|
Zhang, Jiayi |
|
|
25 |
6 |
p. 1050-1059 |
artikel |
7 |
Determinants of clinical outcomes of gastric cancer patients treated with neoadjuvant chemotherapy: a sub-analysis of the PRODIGY study
|
Kim, Hyung-Don |
|
|
25 |
6 |
p. 1039-1049 |
artikel |
8 |
Development of the PERI-Gastric (PEritoneal Recurrence Index) and PERI-Gram (Peritoneal Recurrence Index NomoGRAM) for predicting the risk of metachronous peritoneal carcinomatosis after gastrectomy with curative intent for gastric cancer: a methodology issue
|
Zhang, Wen-Li |
|
|
25 |
6 |
p. 1129-1130 |
artikel |
9 |
Heterogeneity and evolution of tumour immune microenvironment in metastatic gastroesophageal adenocarcinoma
|
Wang, Wei |
|
|
25 |
6 |
p. 1017-1030 |
artikel |
10 |
Impact of body composition on survival of PD-1/PD-L1-treated metastatic gastro-esophageal junction/gastric cancer
|
Morelli, C. |
|
|
25 |
6 |
p. 1123-1124 |
artikel |
11 |
International Delphi consensus guidelines for follow-up after prophylactic total gastrectomy: the Life after Prophylactic Total Gastrectomy (LAP-TG) study
|
Roberts, Geoffrey |
|
|
25 |
6 |
p. 1094-1104 |
artikel |
12 |
Marked improvement of severe reflux esophagitis following proximal gastrectomy with esophagogastrostomy by the right gastroepiploic vessels-preserving antrectomy and Roux-en-Y biliary diversion
|
Hojo, Yudai |
|
|
25 |
6 |
p. 1117-1122 |
artikel |
13 |
Open versus laparoscopic gastrectomy for advanced gastric cancer: a propensity score matching analysis of survival in a western population—on behalf of the Italian Research Group for Gastric Cancer
|
Lombardi, Pietro Maria |
|
|
25 |
6 |
p. 1105-1116 |
artikel |
14 |
Pattern of lymph node metastases in gastric cancer: a side-study of the multicenter LOGICA-trial
|
de Jongh, Cas |
|
|
25 |
6 |
p. 1060-1072 |
artikel |
15 |
PD-L1 IHC testing: issues with interchangeability evidence based on laboratory-developed assays of unknown analytical performance
|
Torlakovic, Emina Emilia |
|
|
25 |
6 |
p. 1131-1132 |
artikel |
16 |
Recurrence of gastric cancer caused by implantation of tumor cells after percutaneous transesophageal gastrostomy
|
Kamada, Teppei |
|
|
25 |
6 |
p. 1127-1128 |
artikel |
17 |
Reply to: Letter to editor on the article “Choice of PD-L1 immunohistochemistry assay influences clinical eligibility for gastric cancer immunotherapy”
|
Yeong, Joe |
|
|
25 |
6 |
p. 1133-1135 |
artikel |
18 |
Survival trends in gastric cancer patients between 1987 and 2016: a population-based cohort study in Finland
|
Maharjan, Urgena |
|
|
25 |
6 |
p. 989-1001 |
artikel |
19 |
The feasibility and safety of endoscopic submucosal dissection of gastric lesions larger than 5 cm
|
Chiba, Hideyuki |
|
|
25 |
6 |
p. 1031-1038 |
artikel |
20 |
Usefulness of an S-1 dosage formula: an exploratory analysis of randomized clinical trial (JCOG1001)
|
Kawakami, Takeshi |
|
|
25 |
6 |
p. 1073-1081 |
artikel |